Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Endocrine
|
April 20, 2006
Obesity
Eugene N Bush
Endocrine
|
June 21, 2006
Chronic treatment with either dexfenfluramine or sibutramine in diet-switched diet-induced obese mice
Eugene N Bush, Robin Shapiro, Michael E Brune, et al.
Journal of Medicinal Chemistry
|
February 20, 2004
Nonpeptide luteinizing hormone-releasing hormone antagonists derived from erythromycin A: design, synthesis, and biological activity of cladinose replacement analogues
John T Randolph, Philip Waid, Charles Nichols, et al.
Basic & Clinical Pharmacology & Toxicology
|
September 28, 2004
In vitro optimization of structure activity relationships of analogues of A-331440 combining radioligand receptor binding assays and micronucleus assays of potential antiobesity histamine H3 receptor antagonists
Arthur A Hancock, Marilyn S Diehl, Ramin Faghih, et al.
European Journal of Pharmacology
|
March 23, 2004
Antiobesity effects of A-331440, a novel non-imidazole histamine H3 receptor antagonist
Arthur A Hancock, Youssef L Bennani, Eugene N Bush, et al.
Journal of Rnai and Gene Silencing : an International Journal of RNA and Gene Targeting Research
|
September 23, 2009
Delivery of RNAi reagents in murine models of obesity and diabetes
Denise M Wilcox, Ruojing Yang, Sherry J Morgan, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 25, 2005
Synthesis and evaluation of urea-based indazoles as melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity
Andrew J Souers, Ju Gao, Dariusz Wodka, et al.
The Journal of Biological Chemistry
|
June 7, 2007
Liver-specific knockdown of JNK1 up-regulates proliferator-activated receptor gamma coactivator 1 beta and increases plasma triglyceride despite reduced glucose and insulin levels in diet-induced obese mice
Ruojing Yang, Denise M Wilcox, Deanna L Haasch, et al.
Journal of Medicinal Chemistry
|
April 14, 2006
2,4-diaminopyrimidine derivatives as potent growth hormone secretagogue receptor antagonists
Michael D Serby, Hongyu Zhao, Bruce G Szczepankiewicz, et al.
Journal of Medicinal Chemistry
|
July 21, 2006
Discovery and pharmacological evaluation of growth hormone secretagogue receptor antagonists
Zhili Xin, Michael D Serby, Hongyu Zhao, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Endocrine
|
April 20, 2006
Obesity
Eugene N Bush
Endocrine
|
June 21, 2006
Chronic treatment with either dexfenfluramine or sibutramine in diet-switched diet-induced obese mice
Eugene N Bush, Robin Shapiro, Michael E Brune, et al.
Journal of Medicinal Chemistry
|
February 20, 2004
Nonpeptide luteinizing hormone-releasing hormone antagonists derived from erythromycin A: design, synthesis, and biological activity of cladinose replacement analogues
John T Randolph, Philip Waid, Charles Nichols, et al.
Basic & Clinical Pharmacology & Toxicology
|
September 28, 2004
In vitro optimization of structure activity relationships of analogues of A-331440 combining radioligand receptor binding assays and micronucleus assays of potential antiobesity histamine H3 receptor antagonists
Arthur A Hancock, Marilyn S Diehl, Ramin Faghih, et al.
European Journal of Pharmacology
|
March 23, 2004
Antiobesity effects of A-331440, a novel non-imidazole histamine H3 receptor antagonist
Arthur A Hancock, Youssef L Bennani, Eugene N Bush, et al.
Journal of Rnai and Gene Silencing : an International Journal of RNA and Gene Targeting Research
|
September 23, 2009
Delivery of RNAi reagents in murine models of obesity and diabetes
Denise M Wilcox, Ruojing Yang, Sherry J Morgan, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 25, 2005
Synthesis and evaluation of urea-based indazoles as melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity
Andrew J Souers, Ju Gao, Dariusz Wodka, et al.
The Journal of Biological Chemistry
|
June 7, 2007
Liver-specific knockdown of JNK1 up-regulates proliferator-activated receptor gamma coactivator 1 beta and increases plasma triglyceride despite reduced glucose and insulin levels in diet-induced obese mice
Ruojing Yang, Denise M Wilcox, Deanna L Haasch, et al.
Journal of Medicinal Chemistry
|
April 14, 2006
2,4-diaminopyrimidine derivatives as potent growth hormone secretagogue receptor antagonists
Michael D Serby, Hongyu Zhao, Bruce G Szczepankiewicz, et al.
Journal of Medicinal Chemistry
|
July 21, 2006
Discovery and pharmacological evaluation of growth hormone secretagogue receptor antagonists
Zhili Xin, Michael D Serby, Hongyu Zhao, et al.
Page
of 2